vastly increases the likelihood of incapacity. 2 A variety of validated tools exist to aid the assessment of decision-making capacity such as the MacArthur Competence Assessment Tool for Treatment (MacCAT-T). Clinicians often overestimate their patient's decision-making capacity. 2, 3 Raymont et al 4 investigated the prevalence of mental incapacity in a cross-sectional study in London and found that incapacity was rarely detected by clinicians or relatives. While the authors noted there was little conflict between patients and treating physicians with regard to treatment decisions, it still leaves the possibility of patients making decisions they do not have the capacity to make. There is a potential for clinical harm, as well as the violation of autonomous choices, if protective measures are not in place because a patient is wrongly assumed to have decision-making capacity.
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No review so far has compared prevalence of incapacity in two or more different settings. The aim of our review is to estimate the prevalence of incapacity to consent to treatment or admission in different settings. We have included medical and psychiatric patients covering inpatient, outpatient and other settings as well as subspecialities within psychiatry. The results provide guidance to the level of incapacity that clinicians should expect in a variety of different settings. We also compared medical and psychiatric settings to see whether there is a significant difference.
Methods
We followed PRISMA principles for systematic reviews. We searched all articles published until November 2013 in Embase, Medline or Psychinfo. We used the following search terms: mental competency/or capacity assessments or decision making/informed consent/or consent to treatment in medical wards or hospital units/inpatients or inpatients hospitals, psychiatric/or schizophrenia/or depressive disorder/or mental disorders/or psychiatric patients substance-related disorders/or mood disorders.
Inclusion criteria:
> participants: any medical or psychiatric patients > assessment: conducted with a validated tool > data about the prevalence of incapacity were either stated directly or were possible to calculate from the available data > data were presented in a binary way (either patients had capacity or not) > any setting including mixed settings > reporting: published in peer review journals and available as electronic or paper full text in any language.
Introduction
Decision-making capacity is the basis for medical decision making. Many countries have introduced legislation to regulate decision making for people who lack capacity; in England and Wales this is the Mental Capacity Act (MCA), 2005. 1 However, there is little guidance to aid clinicians to estimate the expected prevalence of incapacity on their wards. Previous studies suggested that a mini mental state examination score below Abstracts were cross-checked and full text articles were independently screened by two authors. Any differences were discussed and settled. We calculated average percentage prevalence of incapacity for various subsettings separating medical and psychiatric settings. We calculated the statistical differences between medical and psychiatric settings. We made the reasonable assumption that due to the large number of studies heterogeneity could be significant, so initial analysis used the random effects model. Table S1 summarises the included studies.
Search results

Results
Estimates of prevalence and heterogeneity
A common solution to analysis where the dependent variable is a proportion is to use a logit transform. The inverse variation weighted prevalence for decision-making capacity for all included studies was 41% (95% CI 35.6-46.2%). Heterogeneity was significant (Cochran Q 601; degrees of freedom (df) 69; p<0.001). Differences between all studies were large, therefore requiring a random effects model. The inconsistency value shows the amount of variation between studies due to heterogeneity was 89% (95% CI 86-91%). The test for subgroup differences was not significant (Cochran Q 0.66; df 1; p=0.42). For psychiatric settings, the inverse variance weighted proportion of patients with incapacity was 45% (95% CI 39-51%). Heterogeneity was significant (Cochran Q 300; df 42; p<0.001). Variance between studies was large (I 2 inconsistency 86% (95% CI 82-89%)), meaning the amount of variation between studies due to heterogeneity was 86%.
For medical settings the inverse variance weighted proportion of patients with incapacity was 34% (95% CI 25-44%). Heterogeneity was significant (Cochran Q 267; df 26; p<0.001), with inconsistency I 2 at 90% (95% CI 87-93%), showing variation between studies due to heterogeneity was 90%.
Comparing medical and psychiatric settings Table 1 shows the average percentage results for all subsettings. Psychiatric and medical settings are not significantly different from each other in terms of the proportion of incapacity (Cochran Q 0.66; df 1; p=0.44).
Discussion
Our results show the average percentage of patients with incapacity on psychiatric wards is 45%. In medical settings the number is slightly lower with 34%. The figures shown above are similar to results from previous reviews, and we found no significant difference between psychiatric and medical settings. However, differences between diagnostic groups within psychiatry have been shown to be significant in previous studies. Patients with psychosis, dementia and mania are much more likely to lack decision-making capacity than those with depression or personality disorder. 36, 37, 58 In medicine, our results suggest a large number of patients lack decision-making capacity, with known higher levels of incapacity in those with learning disability, delirium and neurological disease. 41 
Comparisons with other studies
A variety of studies have looked at the prevalence of mental incapacity in medical and psychiatric settings but there have only been two systematic reviews 2, 59 and no review has compared medical and psychiatric percentage prevalence data before. For psychiatric settings, Okai et al 59 compared a variety of decisions for which decision-making capacity was tested, but many of these decisions, such as admission or specific treatments, only had a small number of studies included with a wide variety of results. In the famous CATIE study the authors looked at the longitudinal consent-related abilities among research participants with schizophrenia, and found that 56% of 1,158 participants had a stable pattern of MacCAT-clinical research (CR) understanding scores, with 24% deteriorating and 20% improving over an 18-month period. 60 Sessums et al 2 examined the prevalence of incapacity and the accuracy of capacity assessments in adult medical patients. They concluded that 26% of medical patients lacked capacity compared with 3% of healthy elderly controls. They added that 'while physicians routinely missed the diagnosis of incapacity (only recognising 42% of incapable patients), they were usually correct when they made the diagnosis'. Owen et al 61 found qualitative differences in incapacity between psychiatric and medical patients. They concluded that 'the appreciation ability had more salience to decision-making capacity in a psychiatric setting and the reasoning ability had more salience in the medical setting', thus confirming that the two settings have different priority problems in terms of capacity.
While appreciation of the problem or necessity for treatment is more prominent in psychiatric patients who lack decisionmaking capacity, medical patients primarily struggle with reasoning when they lack decision-making capacity. When we looked at different settings, such as inpatients versus outpatients in various types of psychiatric settings, the differences were smaller than we expected and not statistically significant. Similarly, differences between inpatients and outpatients in either medical or psychiatric settings were not statistically significant. 
Considering the legal context
To put these figures into a current context, the MCA in England and Wales and the Adults with Incapacity (Scotland) Act 2000 for Scotland set out the legislative frameworks for clinicians describing the process of how to deal with incapable patients and how to act in their best interest. For England and Wales, the recent Supreme Court decisions on the linked appeals regarding the cases of P versus Cheshire West and Chester Council and P and Q versus Surrey County Council 62 have changed the obligation on hospitals and registered care homes to apply for an authorisation under the Deprivation of Liberty Safeguards (DoLS) when a patient who lacks capacity is subject to continuous supervision and control, and not free to leave. These two questions were termed the 'acid test' by Lady Hale in the Supreme Court judgment. 63 This scenario is common in hospital settings with regard to patients who lack decision-making capacity. In fact, our results show that lack of decision-making capacity should be assumed in at least 17% of medical patients at any one time, most of whom will be subject to continuous supervision and control because of the institutionalised way in which hospitals operate, and would not be free to leave if they wanted to. A possible consequence is a sharp increase in DoLS applications, which will have significant resource implications as the process is cumbersome. The UK government has already asked the Law Commission to review the DoLS legislation.
Limitations and strengths
This meta-analysis yielded a high level of heterogeneity between studies. Even though we only included studies with valid measurement tools, it is not clear those tools could always answer questions around law and ethics. In addition, cut-off points for various tools are still being investigated. The high level of heterogeneity between studies is an important limiting factor that requires a cautious interpretation of our results. In studies about incapacity in different settings, some heterogeneity is expected because of the nature of the research topic. There is also a risk of sampling bias in the available data because of the settings chosen. However, we included more participants than any previous review of this kind, which is its main strength. For the first time, we have directly compared psychiatric with medical patients and attempted to cluster results by subsettings. However, particular caution is necessary when interpreting the results about subsettings because of the often highly selective nature of the patient populations in those settings (for example dementia patients in outpatient settings). In addition, we did not weight the studies according to their quality. We included two subgroup samples with results such as 100% decision-making incapacity. These studies did, however, not contribute much to the overall result because of their very small sample sizes.
Conclusions and practical implications
We have examined decision-making capacity across different types of treatment decisions using different, but validated measures of decision-making incapacity. We did not find any difference between medical and psychiatric populations in the frequency of decision-making incapacity when variously measured. The results of this review should serve as a pertinent reminder to clinicians to consider carefully how much capacity an individual patient has. While the legislative frameworks assert an assumption of capacity, in reality, clinicians often assume capacity where it may be lacking. The consequences of this are less frequent and less rigorous discussions about the best interests or potential detriment to the patient. More caution and more frequent capacity assessments are needed to rectify this situation. ■
